Aricept to Improve Functional Tasks in Vascular Dementia

PHASE1UnknownINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
StrokeVascular DementiaMemory Deficits
Interventions
DRUG

Donepezil and self-generated memory training

Aricept 5 mg PO qd for 4 weeks followed by Aricept 10 mg PO qd for 8 weeks

DRUG

Donepezil and experimenter-administered memory training

Aricept 5 mg PO daily for 4 weeks followed by Aricept 10 mg PO qd for 8 weeks

Trial Locations (1)

08902

Kessler Foundation, West Orange

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Kessler Foundation

OTHER

NCT00457769 - Aricept to Improve Functional Tasks in Vascular Dementia | Biotech Hunter | Biotech Hunter